All MCI patients showed a marked strengthening in the correlations of CSF αSyn to CSF Aβ1–40, t-tau, and p-tau between baseline and 12-months, and were the strongest in the MCI-AD group compared to all other groups at 12-months (Table 2). The gene discussed is MAPT; the disease is Alzheimer disease.